Craig Laferty

Craig Laferty is an accomplished professional with extensive experience in the pharmaceutical industry, currently serving as the Senior Director and Head of US Rare Disease Marketing at Alnylam Pharmaceuticals since August 2022. Prior to this role, Craig held the position of Senior Area Sales Director at HUTCHMED from June 2021 to August 2022. Craig's earlier experience includes significant roles at Ipsen, where responsibilities ranged from Senior Director of US Oncology Marketing to Director of Oncology Marketing, and from Director of DTP Marketing. At Eisai, Craig progressed through various positions including Senior Product Manager in Oncology Marketing and Sr. Manager for Strategic Pricing & Contracting. Craig Laferty holds a Bachelor of Science degree in Biology from the University of Maryland.